Acute lung injury and acute respiratory distress syndrome: A genomic perspective;Lesión pulmonar aguda y síndrome de distrés respiratorio agudo: una perspectiva genómica

Medicina Intensiva

Volumn 35, Issue 6, 2011, Pages 361-372

  Cardinal Fernandez P ^a   Nin, N ^b   Lorente, J A ^b  

^a HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

ALI; ARDS; Critical care; Genomic; Polymorphism; Susceptibility

Indexed keywords

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL PRACTICE; GENETIC POLYMORPHISM; GENOME ANALYSIS; HUMAN; MEDICAL SOCIETY; PROCESS OPTIMIZATION; PROFESSIONAL KNOWLEDGE; PROGNOSIS; RISK REDUCTION; SHORT SURVEY;

ACUTE LUNG INJURY; GENOMICS; HUMANS; POLYMORPHISM, GENETIC; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 79960286561     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2011.02.002     Document Type: Short Survey

References (90)

1. Varmus H. Ten Years On - The Human Genome and Medicine. N Engl J Med. 2010, 27:2028-2029.
2. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science. 2001, 291:1304-1351.
3. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin A., et al. Initial sequencing and analysis of the human genome. Nature. 2001, 409:860-921.
4. Butler D. Science after the sequence. Nature. 2010, 465:1000-1001.
5. Florez J.C. Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008. J Clin Endocrinol Metab. 2008, 93:4633-4642.
6. McCarthy M.I., Zeggini E. Genome-wide association studies in type 2 diabetes. Curr Diab Rep. 2009, 9:164-171.
7. Arora P., Newton-Cheh C. Blood pressure and human genetic variation in the general population. Curr Opin Cardiol. 2010, 25:229-237.
8. Binder A. A review of the genetics of essential hypertension. Curr Opin Cardiol. 2007, 22:176-184.
9. Frutos F., Nin N., Esteban E. Epidemiology of acute lung injury and acute respiratory distress syndrome. Current Opin Crit Care. 2004, 10:1-5.
10. Manteiga E., Martínez O., Frutos F. Epidemiologia del daño pulmonar agudo y síndrome de distress respiratorio agudo. Med Intensiva. 2006, 30:151-161.
11. Gao L, Barnes KC. Recent advances in genetic predisposition to clinical acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2009;296:L713-25.
12. Won Hong K., Oh B. Overview of personalized medicine in the disease genomic era. BMB Report. 2010, 43:643-648.
13. Frueh F.W., Amur S., Mummaneni P., Epstein R.S., Aubert R.E., DeLuca T.M., et al. Pharmacogenomic biomarker information in drug labels approved the United States Food and Drug Administration: Prevalence of related drug use. Pharmacotherapy. 2008, 28:992-998.
14. Guttmacher A., Porteous M., Mclerrney J. Educating health-care professionals about genetics and genomics. Nature Review. 2007, 8:151-157.
15. Pearson T., Manolio T. How to Interpret a Genome-wide Association Study. JAMA. 2008, 299:1335-1344.
16. The International HapMap Consortium A Haplotype Map of the Human Genome. Nature. 2005, 437:1299-1320.
17. The International HapMap Consortium A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007, 449:851-861.
18. Attia J., Ioannidis J.P., Thakkinstian A., McEvoy M., Scott R.J., Minelli C., et al. How to use an article about genetic association. A: Background Concepts. JAMA. 2009, 301:74-81.
19. Blasi F., Carmeliet P. uPAR: a versatile signaling orchestrator. Nat Rev Mol Cell Biol. 2002, 3:932-943.
20. Idell S. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit Care Med. 2002, 30:S274-S280.
21. Arcaroli J., Sankoff J., Liu N., Allison D.B., Maloney J., Abraham E. Association between urokinase haplotypes and outcome from infection-associated acute lung injury. Intensive Care Med. 2008, 34:300-307.
22. Schroeder O., Schulte K.M., Schroeder J., Ekkernkamp A., Laun R.A. The -1082 interleukin-10 polymorphism is associated with acute respiratory failure after major trauma: a prospective cohort study. Surgery. 2008, 143:233-242.
23. Katzenstein A.L., Bloor C.M., Leibow A.A. Diffuse alveolar damage - the role of oxygen, shock and related factors. A review. Am J Pathol. 1976, 85:209-228.
24. Tomashefki J.F. Pulmonary pathology of acute respiratoy distress syndrome. Clin Chest Med. 2000, 21:435-466.
25. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., et al. Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med. 1994, 149:818-824. The American/European Consensus Conference on ARDS.
26. Villar J., Pérez-Méndez L., López J., Belda J., Blanco J., Saralegui I., et al. An early PEEP/Fio2 trial identifies different degrees of lung injury in patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2007, 176:795-804.
27. Gowda M.S., Klocke R.A. Variability of indices of hypoxemia in adult respiratory distress syndrome. Crit Care Med. 1997, 25:41-45.
28. Ferguson N.D., Kacmarek R.M., Chiche J.D., Singh J.M., Hallett D.C., Mehta S., et al. Screening of ARDS patients using standardized ventilator settings: influence on enrollment in a clinical trial. Intensive Care Med. 2004, 30:1111-1116.
29. Suárez Sipmann F. Utilidad de las maniobras de reclutamiento (pro). Med Intensiva. 2009, 33:134-138.
30. Ochagavia A., Blanch L., López-Aguilar J. Utilidad de las maniobras de reclutamiento (contra). Med Intensiva. 2009, 33:139-143.
31. Martínez O., Nin N., Esteban A. Evidencias de la posición en decúbito prono para el tratamiento del síndrome de distrés respiratorio agudo: una puesta al día. Arch Bronconeumol. 2009, 45:291-296.
32. Sud S., Friedrich J.O., Taccone P., Polli F., Adhikari N.K., Latini R., et al. Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med. 2010, 36:585-599.
33. Rubenfeld G.D., Caldwell E., Granton J.T., Hudson L.D., Matthay M.A. Interobserver Variability in Applying a Radiographic Definition for ARDS. Chest. 1999, 116:1347-1353.
34. Meade M.O., Cook R.J., Guyatt G.H., Groll R., Kachura J.R., Bedard M., et al. Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome. Am J Resp Crit Care Med. 2000, 161:85-90.
35. Ferguson N., Frutos F., Esteban A., Fernández P., Aramburu J.A., Nájera L., et al. Acute respiratory distress syndrome: Underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med. 2005, 33:2228-2234.
36. Esteban A., Fernández-Segoviano P., Frutos-Vivar F., Aramburu J.A., Nájera L., Ferguson N.D., et al. Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med. 2004, 141:440-445.
37. Hardy J., Singleton A. Genomewide association studies and human disease. N Engl J Med. 2009, 360:1759-1768.
38. Wang W.Y., Barratt B.J., Clayton D.G., Todd J.A. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet. 2005, 6:109-118.
39. Terwilliger J.D., Hiekkalinna T. An utter refutation of the " Fundamental Theorem of the HapMap" Eur J Hum Genet. 2006, 14:426-437.
40. Sirgo G., Rello J., Biodi M., Díaz E., Pérez Vela J.L., Hernández G., et al. Polimorfismo genético en el paciente crítico (I). Aspectos generales, inflamación y sépsis. Med Intensiva. 2003, 27:24-31.
41. Arcaroli J.J., Hokanson J.E., Abraham E., Geraci M., Murphy J.R., Bowler R.P., et al. Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. Am J Respir Crit Care Med. 2009, 179:105-112.
42. Su L., Zhai R., Sheu C.C., Gallagher D.C., Gong M.N., Tejera P., et al. Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS. Intensive Care Med. 2009, 35:1024-1030.
43. Gong M.N., Thompson B.T., Williams P.L., Zhou W., Wang M.Z., Pothier L., et al. Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome. Eur Respir J. 2006, 27:674-681.
44. Marshall R.P., Webb S., Hill M.R., Humphries S.E., Laurent G.J. Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest. 2002, 121:68S-69S.
45. Villar J., Flores C., Pérez-Méndez L., Maca-Meyer N., Espinosa E., Blanco J., et al. Angiotensin-converting enzyme insertion/deletion polymorphism is not associated with susceptibility and outcome in sepsis and acute respiratory distress syndrome. Intensive Care Med. 2008, 34:488-495.
46. Adamzik M., Frey U.H., Riemann K., Sixt S., Lehmann N., Siffert W., et al. Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndrome. Crit Care Med. 2008, 36:1776-1779.
47. Flores C., Ma S.F., Maresso K., Wade M.S., Villar J., Garcia J.G. IL6 gene-wide haplotype is associated with susceptibility to acute lung injury. Transl Res. 2008, 152:11-17.
48. Tsangaris I., Tsantes A., Bonovas S., Lignos M., Kopterides P., Gialeraki A., et al. The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. Thromb Res. 2009, 123:832-836.
49. Tejera P., Wang Z., Zhai R., Su L., Sheu C.C., Taylor D.M., et al. Genetic polymorphisms of peptidase inhibitor 3 (elafin) are associated with acute respiratory distress syndrome. Am J Respir Cell Mol Biol. 2009, 41:696-704.
50. Quasney M.W., Waterer G.W., Dahmer M.K., Kron G.K., Zhang Q., Kessler L.A., et al. Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med. 2004, 32:1115-1119.
51. Gong M.N., Wei Z., Xu L.L., Miller D.P., Thompson B.T., Christiani D.C. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest. 2004, 125:203-211.
52. Currier P.F., Gong M.N., Zhai R., Pothier L.J., Boyce P.D., Xu L., et al. Surfactant protein-B polymorphisms and mortality in the acute respiratory distress syndrome. Crit Care Med. 2008, 36:2511-2516.
53. Adamzik M., Frey U.H., Rieman K., Sixt S., Beiderlinden M., Siffert W., et al. Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. Intensive Care Med. 2007, 33:1199-1203.
54. Gong M.N., Zhou W., Williams P.L., Thompson B.T., Pothier L., Christiani D.C. Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med. 2007, 35:48-56.
55. Sheu C.C., Zhai R., Wang Z., Gong M.N., Tejera P., Chen F., et al. Heme oxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acute respiratory distress syndrome. Intensive Care Med. 2009, 35:1343-1351.
56. Sheu C.C., Zhai R., Su L., Tejera P., Gong M.N., Thompson B.T., et al. Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome. Eur Respir J. 2009, 33:543-550.
57. Lagan A.L., Quinlan G.J., Mumby S., Melley D.D., Goldstraw P., Bellingan G.J., et al. Variation in iron homeostasis genes between patients with ARDS and healthy control subjects. Chest. 2008, 133:1302-1311.
58. Marshall R.P., Webb S., Bellingan G.J., Montgomery H.E., Chaudhari B., McAnulty R.J., et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002, 166:646-650.
59. Jerng J.S., Yu C.J., Wang H.C., Chen K.Y., Cheng S.L., Yang P.C. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med. 2006, 34:1001-1006.
60. Adamzik M., Frey U., Sixt S., Knemeyer L., Beiderlinden M., Peters J., et al. ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir J. 2007, 29:482-488.
61. Gao L., Grant A., Halder I., Brower R., Sevransky J., Maloney J.P., et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol. 2006, 34:487-495.
62. Christie J.D., Ma S.F., Aplenc R., Li M., Lanken P.N., Shah C.V., et al. Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma. Crit Care Med. 2008, 36:2794-2800.
63. Gong M.N., Zhou W., Williams P.L., Thompson B.T., Pothier L., Boyce P., et al. -308GA and TNFB polymorphisms in acute respiratory distress syndrome. Eur Respir J. 2005, 26:382-389.
64. Zhai R., Zhou W., Gong M.N., Thompson B.T., Su L., Yu C., et al. Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians. Crit Care Med. 2007, 35:893-898.
65. Medford A.R., Keen L.J., Bidwell J.L., Millar A.B. Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax. 2005, 60:244-248.
66. Ognjanovic S., Bryant-Greenwood G.D. Pre-B cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol. 2002, 187:1051-1058.
67. Rongvaux A., Shea R.J., Mulks M.H., et al. Pre-Bcell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol. 2002, 32:3225-3234.
68. Van der Veer E., Nong Z., O'Neil C., Urquhart B., Freeman D., Pickering J.G. Pre-B-cell colony-enhancing factor regulates NAD-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res. 2005, 97:25-34.
69. Ye S.Q., Zhang L.Q., Adyshev D., Usatyuk P.V., Garcia A.N., Lavoie T.L., et al. Pre-B-cellcolony- enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. Microvasc Res. 2005, 70:142-151.
70. Ognjanovic S., Bao S., Yamamoto S.Y., Garibay-Tupas J., Samal B., Bryant-Greenwood G.D. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol. 2001, 26:107-117.
71. Ye S.Q., Simon B.A., Maloney J.P., Zambelli-Weiner A., Gao L., Grant A., et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med. 2005, 171:361-370.
72. Bajwa E.K., Yu C.L., Gong M.N., Thompson B.T., Christiani D.C. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med. 2007, 35:1290-1295.
73. Attia J., Ioannidis J., Thakkinstian A., McEvoy M., Scott R., Minelli C., et al. How to use an article about genetic association. B: Are the Results of the study valid?. JAMA. 2009, 301:191-197.
74. Akey J.M., Zhang K., Xiong M., Doris P., Jin L. The effect that genotyping errors have on the robustness of common linkage-disequilibrium measures. Am J Hum genet. 2001, 68:1447-1456.
75. Leal S.M. Detection of genotyping errors and pseudo-SNPs via deviations from Hardy-Weinberg equilibrium. Genet Epidemiol. 2005, 29:204-214.
76. Hosking L., Lumsden S., Lewis K., Yeo A., McCarthy L., Bansal A., et al. Detection of genotyping errors by Hardy-Weinberg equilibrium testing. Eur J Hum Genet. 2004, 12:395-399.
77. Flores C., Pino-Yanes M., Villar J. A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Critical Care. 2008, 12:R120.
78. Vandenbroucke J.P., Von Elm E., Altman D.G., Gotzsche P.C., Mulrow C.D., Pocock S.J., et al. STROBE initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007, 147:163-194.
79. Little J., Higgins J., Ioannidis J., Moher D., Gagnon F., Von Elm E., et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet. 2009, 125:131-151.
80. Sorensen T.I., Nielsen G.G., Andersen P.K., Teasdale T.W. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 1988, 318:727-732.
81. Evans W.E., Relling M. Moving towards individualized medicine with pharmacogenomics. Nature. 2004, 429:464-468.
82. Evans W.E., Relling M. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999, 286:487-491.
83. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature. 2009, 461:747-753.
84. Flores C., Pino-Yanes M.M., Casula M., Villar J. Genetics of acute lung injury: past, present and future. Minerva Anestesiol. 2010, 76:860-864.
85. Sanger F., Coulson A. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol. 1975, 94:441-448.
86. Sanger F., Nicklen S., Coulson A. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977, 74:5463-5467.
87. Schadt E., Turner S., Kasarkis A. A window into third-generation sequencing. Human Molecular Genetics. 2010, 19:227-240.
88. Mamanova L., Coffey A.J., Scott C.E., Kozarewa I., Turner E.H., Kumar A., et al. Target-enrichment strategies for next-generation sequencing. Nat Methods. 2010, 7:111-118.
89. Summerer D. Enabling technologies of genomic-scale sequence enrichment for targeted high-throughput sequencing. Genomics. 2009, 94:363-368.
90. Turner E.H., Ng S.B., Nickerson D.A., Shendure J. Methods for genomic partitioning. Annu Rev Genomics Hum Genet. 2009, 10:263-284.